|
|
||||||||
The FASEB Journal, Vol 10, 777-784, Copyright © 1996 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
G Schonfelder, M John, H Hopp, N Fuhr, M van Der Giet and M Paul
Department of Clinical Pharamacology, Bejamin Franklin University Hospital, Freie Universitat Berlin, Germany.
Gestational diabetes is one of the most prevalent medical complications of pregnancy and causes increased fetal wastage. Investigation of placentas from diabetic mothers indicate chronic disturbances in intervillous, circulation, dilatation of capillaries, and a relatively immature villous structure. Abnormal levels of nitric oxide (NO) may contribute to maternal disorders such as the pathogenesis of diabetic vascular complications. In the normal placenta NO is generated only by endothelial NOS, which apparently serves to regulate vascular tone in the fetoplacental circulation. In contrast, studies have reported the absence of inducible nitric oxide synthase (iNOS) in human placentas under normal conditions. The aim of our study was to investigate whether iNOS is expressed in placentas from patients with gestational diabetes. Reverse transcription-polymerase chain reaction and Western blot analysis demonstrated iNOS mRNA and protein expression in placental tissue only from patients with gestational diabetes. Immunohistochemistry localized iNOS staining to endothelial cells and trophoblasts. We conclude that iNOS can be expressed in human placenta. Its expression might play an important role in placental pathophysiology.
This article has been cited by other articles:
![]() |
M C Pustovrh, A Jawerbaum, V White, E Capobianco, R Higa, N Martinez, J J Lopez-Costa, and E Gonzalez The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats Reproduction, October 1, 2007; 134(4): 605 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Menendez, O. Krysiak, A. Inga, B. Krysiak, M. A. Resnick, and G. Schonfelder A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network PNAS, January 31, 2006; 103(5): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Krysiak, A. Bretschneider, E. Zhong, J. Webb, H. Hopp, S. Verlohren, N. Fuhr, M. Lanowska, A. Nonnenmacher, R. Vetter, et al. Soluble Vascular Endothelial Growth Factor Receptor-1 (sFLT-1) Mediates Downregulation of FLT-1 and Prevents Activated Neutrophils From Women With Preeclampsia From Additional Migration by VEGF Circ. Res., December 9, 2005; 97(12): 1253 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jawerbaum, E. Capobianco, C. Pustovrh, V. White, M. Baier, S. Salzberg, M. Pesaresi, and E. Gonzalez Influence of peroxisome proliferator-activated receptor {gamma} activation by its endogenous ligand 15-deoxy {Delta}12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women Mol. Hum. Reprod., September 1, 2004; 10(9): 671 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Napolitano, F. Miceli, A. Calce, A. Vacca, A. Gulino, R. Apa, and A. Lanzone Expression and Relationship between Endothelin-1 Messenger Ribonucleic Acid (mRNA) and Inducible/Endothelial Nitric Oxide Synthase mRNA Isoforms from Normal and Preeclamptic Placentas J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2318 - 2323. [Abstract] [Full Text] |
||||
![]() |
W. Kossenjans, A. Eis, R. Sahay, D. Brockman, and L. Myatt Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1311 - H1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakatsuka, K. Asagiri, Y. Kimura, Y. Kamada, K. Tada, and T. Kudo Generation of peroxynitrite and apoptosis in placenta of patients with chorioamnionitis: possible implications in placental abruption Hum. Reprod., April 1, 1999; 14(4): 1101 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.A. Baylis, P.J.L.M. Strijbos, A. Sandra, R.J. Russell, A. Rijhsinghani, I.G. Charles, and C.P. Weiner Temporal expression of inducible nitric oxide synthase in mouse and human placenta Mol. Hum. Reprod., March 1, 1999; 5(3): 277 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. HARREN, G. SCHONFELDER, M. PAUL, I. HORAK, E. O. RIECKEN, B. WIEDENMANN, and M. JOHN High Expression of Inducible Nitric Oxide Synthase Correlates with Intestinal Inflammation of Interleukin-2-Deficient Mice Ann. N.Y. Acad. Sci., November 17, 1998; 859(1): 210 - 215. [Full Text] [PDF] |
||||
![]() |
G. M. Pieper Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction Hypertension, May 1, 1998; 31(5): 1047 - 1060. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |